159 related articles for article (PubMed ID: 37670280)
1. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study.
Zhu XX; Li JH; Fang P; Qu XF; Liang LJ; Lai JM; Yin XY
BMC Cancer; 2023 Sep; 23(1):826. PubMed ID: 37670280
[TBL] [Abstract][Full Text] [Related]
2. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
[TBL] [Abstract][Full Text] [Related]
3. Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.
Liu JC; Hsu YP; Wu SY
PLoS One; 2016; 11(9):e0162588. PubMed ID: 27632175
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
Kodama K; Kawaoka T; Kosaka M; Johira Y; Shirane Y; Miura R; Yano S; Murakami S; Amioka K; Naruto K; Ando Y; Kosaka Y; Uchikawa S; Fujino H; Nakahara T; Murakami E; Okamoto W; Yamauchi M; Miki D; Imamura M; Kuroda S; Kobayashi T; Ohdan H; Aikata H; Chayama K
J Gastroenterol; 2022 Sep; 57(9):676-683. PubMed ID: 35849192
[TBL] [Abstract][Full Text] [Related]
5. Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy.
Moriyama S; Hieda M; Kisanuki M; Kawano S; Yokoyama T; Fukata M; Kusaba H; Maruyama T; Baba E; Akashi K; Fukuda H
Open Heart; 2022 Dec; 9(2):. PubMed ID: 36600585
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy.
Feng LH; Sun HC; Zhu XD; Zhang SZ; Li KS; Li XL; Li Y; Tang ZY
Ann Transl Med; 2019 Dec; 7(23):739. PubMed ID: 32042755
[TBL] [Abstract][Full Text] [Related]
7. Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients.
Gori M; Berzuini C; D'Elia E; Ghirardi A; Bernardinelli L; Gavazzi A; Balestrieri G; Giammarresi A; Trevisan R; Di Marco F; Bellasi A; Amoroso M; Raimondi F; Novelli L; Magro B; Mangia G; Lorini FL; Guagliumi G; Fagiuoli S; Parati G; Senni M
J Hypertens; 2022 Apr; 40(4):666-674. PubMed ID: 34889863
[TBL] [Abstract][Full Text] [Related]
8. Association between stopping renin-angiotensin system inhibitors immediately before hemodialysis initiation and subsequent cardiovascular events.
Nakamura Y; Inaguma D; Imaizumi T; Kurasawa S; Hishida M; Okazaki M; Fujishima Y; Nishibori N; Suzuki K; Takeda Y; Maruyama S
Hypertens Res; 2024 May; 47(5):1372-1379. PubMed ID: 38438724
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.
Roush GC; Abdelfattah R; Song S; Kostis JB; Ernst ME; Sica DA
J Hypertens; 2018 Jun; 36(6):1247-1255. PubMed ID: 29465713
[TBL] [Abstract][Full Text] [Related]
10. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
[TBL] [Abstract][Full Text] [Related]
12. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
13. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
14. Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes.
Wintheiser G; Zemla T; Shi Q; Tran N; Prasai K; Tella SH; Mody K; Ahn D; Borad M; Bekaii-Saab T; Mahipal A
JCO Precis Oncol; 2022 Jan; 6():e2100156. PubMed ID: 35005992
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
16. Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium.
Takigawa M; Yamada T; Yoshida Y; Ando M; Ishikawa K; Aoyama Y; Yamamoto T; Inoue N; Tatematsu Y; Nanasato M; Kato K; Tsuboi N; Hirayama H
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):487-95. PubMed ID: 22634400
[TBL] [Abstract][Full Text] [Related]
17. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study.
Hsu WT; Galm BP; Schrank G; Hsu TC; Lee SH; Park JY; Lee CC
Hypertension; 2020 Feb; 75(2):483-491. PubMed ID: 31838905
[TBL] [Abstract][Full Text] [Related]
18. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
Mukund A; V Srinivasan S; Rana S; Vijayaraghavan R; Patidar Y; Arora V; Jindal A; Choudhury A; Shasthry SM; Sarin SK
Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
20. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
